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The advent of systematic reviews is relatively new and represents an important tool to 
summarise the best evidence for studying the effects of healthcare interventions. Without 
systematic reviews, the effectiveness of therapies (or lack of benefit) can remain 
unrecognised for many years. The Cochrane logo (www.cochranelibrary.com) provides a 
good example: it shows the forest plot of a systematic review describing how corticosteroids 
given to women who are about to give birth prematurely can save the life of the newborn 
child, an important summary of the evidence available at the time. Systematic reviews as a 
publication type has increased over the last decade. Initially concerned with therapeutic 
interventions, there are now many more types, from “umbrella” reviews (reviews of reviews) 
to reviews of observational studies and case reports. The methods of the review will depend 
on the question being asked. 
  
Systematic reviews carry an aura of infallibility but are highly dependent on the methods 
used and the quality of information that they summarise. A well performed systematic review 
of high quality randomised controlled trials (RCTs) is usually assigned to the top of the 
evidence pyramid for assessing the effects of interventions. However, a poorly performed 
systematic review that only includes a subset of all relevant evidence with little attempt to 
rate the quality of included studies can produce false conclusions. The review’s position in 
the evidence pyramid is anchored by the quality of its included studies. For example, a 
systematic review of case reports is likely to be misleading due to publication bias affecting 
the included studies, in which reports showing benefit of a new intervention are more likely to 
be published than those showing no benefit. Cochrane reviews are generally more 
methodologically rigorous than non-Cochrane reviews in dermatology1, but are limited to 
studies of interventions and diagnostic test accuracy. These are the types of reviews with 
most established methods2. The Joanna Briggs Institute has also developed methodology 
for qualitative systematic reviews. However, reviews of other types of questions are less well 
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developed and authors have less guidance to ensure a high quality review. The BJD aims to 
publish only excellent systematic reviews of any type. 
 
An advantage of systematic reviews over narrative reviews is that their methods should be 
clearly described and reproducible. This is the objective of reporting guidelines such as 
PRISMA or MOOSE, ensuring complete description of the methods so that the reader can 
judge the quality of the review3,4. In a similar way to registering or publishing the protocol for 
an RCT, the planned methodology for a systematic review should be registered beforehand 
on the International Prospective Register of Systematic Reviews (PROSPERO) so that 
reviewers and readers can judge whether the authors did what they said they would do. 
Cochrane reviews protocols are also published before the review starts. Several tools exist 
for undertaking critical appraisal and methodological quality assessment of systematic 
reviews. Although none has become universally accepted, the AMSTAR tool is probably the 
most commonly used quality assessment tool for systematic reviews of RCTs5. A tool for 
observational studies is being developed.  
 
As in any study, the main concerns that can lead to false results in systematic reviews are 
chance, confounding and bias. These can arise in the original studies and in the process of 
producing the systematic review and can be amplified in the review if steps are not taken to 
mitigate them. 
 
Taking into account the effect of chance is probably the least problematic. It is achieved 
using statistics and tools such as meta-analysis, provided the included studies are 
sufficiently similar to combine in such a way – which is always a matter of judgement. It is 
important to ensure that meta-analysis does not hide, but describes and helps explain 
heterogeneity of results.  
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Confounding is not a big problem in reviews of RCTs because randomization, if done 
properly, decreases confounding. However, for reviews of observational studies, controlling 
for confounding is difficult. Important confounders should be pre-defined and taken into 
account in the review, which can be difficult to achieve if they have not been measured in all 
studies. Even after diligent adjustment, residual confounding due to partial control for known 
confounders or the existence of unknown confounders can cause the results of a review to 
deviate from the truth. 
 
Bias is perhaps the most important issue to assess. Bias can be present in the original 
papers or may be introduced in the process of creating the systematic review. There are 
tools such as the Cochrane risk of bias tool that can be used to evaluate risk of bias in the 
original papers, mostly designed for use with RCTs or the ROBINS-I tool6 for non-
randomized studies of interventions. Risk of bias figures give a useful general overview of 
potential bias within all the included studies, although it can be difficult to use them to 
determine the influence of bias on a particular result. The Grades of Recommendation, 
Assessment, Development and Evaluation (GRADE) approach is a standard method to 
make recommendations on the basis of evidence, and includes tools to assess the quality of 
evidence per outcome2. ConQual7 and CerQual8 have the same purpose of assessing the 
confidence that we can place in qualitative reviews findings. Assessment of risk of bias 
introduced during the process of review is key in the process of peer reviewing systematic 
reviews. New tools such as ROBIS have been developed with this aim9.  
 
An important source of bias in the creation of a review is study selection. Authors should be 
as certain as possible that they have included all relevant studies in their review. The main 
concern is to ensure that studies that could modify the results of the review are not missed. 
These are usually studies with negative results that remain unpublished, or published in 
harder to reach journals. Performing a comprehensive literature search is not easy, 
especially when looking for observational studies. As a letter to the editor by Grindlay in this 
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issue highlights10, seeking the help of a trained information specialist is very useful and has 
been associated with more sensitive searches11.  
 
One additional frequent problem encountered by systematic reviews is outcome measure 
instrument heterogeneity. Outcomes measured in the source studies may be different, 
unvalidated and hence hard to compare and at many times not very useful for patients or 
clinicians. Ongoing efforts to improve homogeneity of outcomes in dermatology, such as 
developing core outcomes for skin conditions in the CSG-COUSIN initiative12, are a step 
forward in this area for future clinical trials, provided that the recommendations for core 
outcome sets are widely disseminated and used. 
 
Keeping systematic reviews trustworthy is important to avoid research waste and to help us 
cope with information overload13. From the BJD perspective, methodological peer-review of 
these papers should be rigorous and ideally include an information specialist, and an expert 
in the methods of systematic reviews. The proliferation of tools to assess the quality of 
information and reviews is an indication of how difficult this can be. We suggest that 
reviewers use tools such as AMSTAR or ROBIS when evaluating the quality of systematic 
reviews. Referees should check that all limitations and differences between protocol and 
review are acknowledged, and that recommendations are based on the evidence present in 
the review. Looking ahead, protocol registration in PROSPERO may in the future become a 
requirement for publication of non-Cochrane systematic reviews in the BJD. 
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